Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
WOO X introduces Futures Credits to help users manage surging BTC volatility
-
Energy CEOs to Canadian leaders: An urgent plan to strengthen economic sovereignty
-
Susan Kudzman Joins nesto’s Board of Directors
-
TransUnion Canada Improves Credit Access for Newcomers and Young Canadians with New Credit Risk Score
-
Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership
-
First Atlantic Nickel and Colorado School of Mines Launch Research Partnership to Explore Geologic Hydrogen Potential in Newfoundland Ophiolites
-
Abits Group Inc Secures Loan for Memphis Expansion, Doubling Mining Capacity by Early April 2025
-
Form 8.3 - Equals Group Plc
-
Springs Heat Up Cultural Tourism Development in Yingkou
-
NEQSOL Holding Announces Second Phase of Women Leadership Development Program
-
Notice to convene the Annual General Meeting of ISS A/S
-
Net Asset Value(s)
-
PrimeXBT Introduces Cashback as a New Way to Redeem Rewards
-
BlackRock® Canada Announces March Cash Distributions for the iShares® ETFs
-
Nexxen Expands U.S. Partnership with Tubi to U.K.
-
Struggling with High Costs and Inefficiencies in Global Gaming Support? GPTBots.ai Reinvents Customer Service with AI
-
Xrpturbo (XRT) Raises 100,000 XRP In Presale—Set To Release Launchpad Demo On XRP Blockchain In Q2 2025
-
MEXC Launches DEX+: One-Stop Platform For Seamless On-Chain and Off-Chain Trading
-
Lantronix Expands Partnership With TD SYNNEX to Distribute Its Out-of-Band, Network Infrastructure and Industrial IoT Solutions Throughout Europe
-
Net Asset Value, Review Update and Dividend Declaration
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Form 8.5 (EPT/RI)-Thruvision Group plc
-
Form 8.5 (EPT/RI)-De La Rue plc
-
White Paper Confirms the Superiority of Svitzer’s New Transverse Tug
-
ELTFV Adopts Distributed Architecture to Build a Secure and Stable Trading System
-
HSBC Continental Europe: Post Stabilisation Notice
-
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
-
Transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Postponement of publication of annual report
-
Shareholder proposal from Constantinsborg A/S regarding delisting of FirstFarms A/S’ shares from trading and official listing on Nasdaq Copenhagen A/S
-
Nykredit announces extension of the offer period
-
Copenhagen Infrastructure Partners reaches financial close on Fengmiao I offshore wind farm
-
ELTFV Launches Multi-Layer Security Protection System to Safeguard User Assets
-
Capgemini accelerates enterprise adoption of agentic AI for industries with NVIDIA
-
Nykredit extends the offer period concerning the recommended, voluntary public tender offer for Spar Nord Bank A/S until 3 April 2025 - Nykredit Realkredit A/S
-
Soitec contributes to accelerated development of integrated optical connectivity solutions for AI datacentres with its silicon photonics SOI technology
-
Optimizing Team Structure to Support Strategic Initiatives by ELTFV Exchange
-
ETAP and Schneider Electric Unveil World’s First Digital Twin to Simulate AI Factory Power Requirements from Grid to Chip Level Using NVIDIA Omniverse
-
Q3 2024 Dividend Exchange Rate
-
Šiaulių Bankas has placed EUR 300 million bond issue in the international market
-
Holding(s) in Company
-
Aspo’s ESL Shipping and SSAB extend long-term cooperation of raw material transports
-
STACK Infrastructure Secures $4 Billion in Green Financing, Strengthening its Position as the Largest Private Data Center Developer in Virginia and Beyond
-
Alm. Brand A/S – Annual General Meeting on 10 April 2025
-
Construction contract (Tapa Army Base Barracks)
-
ELTFV Exchange Expands into the European Market, Actively Adhering to MiCA Regulations
-
Knocknoc Raises Seed Funding to Scale Its Just-In-Time Network Access Control Technology
-
Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
-
ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast
-
Transaction in Own Shares

